Lucid Diagnostics Inc (LUCD) earnings · next report Nov 12, 2026
LUCD earnings call
Call time not announced yet · report Thu, Nov 12
Company investor site: luciddx.com. IR page from the company's last earnings release (Aug 13, 2026).
Next report
Thu, Nov 12, 2026
Before the open · In 8 days
Quarter ended Sep 2026
- EPS consensus
- −$0.05 Range −$0.06 – −$0.053 analystsYear ago −$0.10
- Revenue consensus
- $1.64M Range $1.48M – $1.80M5 analysts
EPS estimate trend
- 90 days ago−$0.06
- 60 days ago−$0.05
- 30 days ago−$0.05
- 7 days ago−$0.06
- Now−$0.06
Consensus −3.1% over 90 days. Last 30 days: 0 up, 1 down revisions.
Date and consensus: EODHD earnings calendar and estimates, refreshed every 6 hours. “Confirmed” means the provider lists the report session, which it sets once the company announces; “Estimated” is the provider’s expected date.
Follow LUCD into its report
Save it to a free watchlist (no card). Alerts when the date moves or results land are part of Pro.
Earnings move
- Options price in (Nov 12)
- — No options snapshot for this report yet (taken daily in the 7 days before a report, for stocks with listed options).
- Average move after earnings
- ±1.0% Absolute close-to-close move, 2 reports
Options-implied move: the at-the-money straddle (call + put) on the first expiry after the report, divided by the stock’s close, from EODHD end-of-day option chains. It is what the options market prices as the absolute move to that expiry, not a forecast of direction. Move: close before the news → close after it (before the open: prior close → report-day close; after the close: report-day close → next close), adjusted for splits and dividends, from EODHD end-of-day prices. Reports with an unannounced time are not averaged: both candidate moves are stored instead. Per-report moves, gaps, moves vs SPY and the sector, beat/miss asymmetry and implied vs actual are in Lician Pro below.
Latest result
EPSAdj.
−$0.07
vs −$0.06 est. −16.7%
Adjusted EPS, provider (EODHD); matches the company press release
Revenue
$1.26M
vs $1.38M est. −9.2%
As filed with the SEC
EPS actuals are checked against the SEC filing and the company’s earnings press release (8-K EX-99.1). A company that reports only GAAP EPS is graded on its SEC diluted EPS; one that reports adjusted EPS is graded on the provider’s adjusted figure when the release confirms it. A figure that matches neither is shown as unverified, with no beat or miss. Revenue actuals come from the SEC filing of the same quarter where we have it.
Beat / miss history
- Missed EPS 2 quarters in a row
- Beat EPS in 0 of 4
- May 13, 2026MissEPS −$0.07Adj. vs −$0.06 −16.7%Rev $1.26M vs $1.38M −9.2%
- Nov 12, 2025MissEPS −$0.10GAAP vs −$0.09 −11.1%Rev $1.21M vs $1.35M −10.6%
- Aug 12, 2025In lineEPS −$0.10Adj. vs −$0.10 0.0%Rev $1.16M vs $1.15M +1.6%
- May 13, 2025MissEPS −$0.16Adj. vs −$0.11 −45.5%Rev $828.00K vs $1.28M −35.3%
| Reported | Quarter | EPS est. | EPS actual | Surprise | Revenue est. | Revenue | Surprise |
|---|---|---|---|---|---|---|---|
| May 13, 2026 | Mar 2026 | −$0.06 | −$0.07Adj. | −16.7% | $1.38M | $1.26MSEC | −9.2% |
| Nov 12, 2025 | Sep 2025 | −$0.09 | −$0.10GAAP | −11.1% | $1.35M | $1.21MSEC | −10.6% |
| Aug 12, 2025 | Jun 2025 | −$0.10 | −$0.10Adj. | 0.0% | $1.15M | $1.16MSEC | +1.6% |
| May 13, 2025 | Mar 2025 | −$0.11 | −$0.16Adj. | −45.5% | $1.28M | $828.00KSEC | −35.3% |
Earnings documents
No earnings 8-K (item 2.02) is stored for this report yet. All LUCD filings: SEC filings.
Documents link to SEC EDGAR. Lician does not publish earnings-call transcripts.
Healthcare peers with similar quant ratings
LUCD among 532 rated Healthcare stocks (Lician quant rating, Nov 4, 2026). How the rating works
- QTTB earnings5.00 · Strong Buy · stock
- AVAH earnings4.99 · Strong Buy · stock
- CDNA earnings4.98 · Strong Buy · stock
- HALO earnings4.97 · Strong Buy · stock
- OSCR earnings4.97 · Strong Buy · stock
- REGN earnings4.95 · Strong Buy · stock
- CON earnings4.94 · Strong Buy · stock
- PACS earnings4.94 · Strong Buy · stock
| Quarter | Revenue | EPS | YoY |
|---|---|---|---|
| Q2 FY26 | $1.47M | −$0.08 | +26.7% |
| Q1 FY26 | $1.26M | −$0.17 | +51.7% |
| Q3 FY25 | $1.21M | −$0.10 | +3.3% |
| Q2 FY25 | $1.16M | −$0.08 | +19.2% |
Lucid Diagnostics Inc (LUCD) is a medical devices company listed on US.
Latest reported LUCD revenue for 2025-12-31 was $4.7M. Net income was -$58.0M. Revenue was up 8.3% from 2024-12-31 to 2025-12-31. LUCD currently screens at market cap $123.3M.
When the next LUCD 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 8.3% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full LUCD research stays on the stock page; the tape stays on the quote page.
LUCD earnings FAQ
When is LUCD's next earnings date?
Lucid Diagnostics Inc (LUCD) is expected to report on Thu, Nov 12, 2026, before the open. The provider lists the session, which it sets once the company announces. Consensus EPS is −$0.05.
When is the LUCD earnings call?
Lucid Diagnostics Inc has not announced the time of its next earnings call in an SEC filing yet. Its investor relations page (luciddx.com) lists the webcast when it is scheduled.
Did LUCD beat earnings estimates last quarter?
No. On May 13, 2026 Lucid Diagnostics Inc (LUCD) reported adjusted EPS of −$0.07 against a −$0.06 consensus (−16.7%), a miss. It reported revenue $1.26M vs $1.38M est. (−9.2%).
How often does LUCD beat EPS estimates?
Lucid Diagnostics Inc (LUCD) beat the EPS consensus in 0 of its last 6 reported quarters. Revenue beat the consensus in 1 of the last 4 quarters with an estimate on file.
What are LUCD's latest revenue and net income?
Latest cached Lucid Diagnostics Inc (LUCD) revenue for Dec 31, 2025 was $4.7M. Net income was -$58.0M. Statements: https://lician.com/financials/lucd
What is LUCD's latest basic EPS?
Latest cached Lucid Diagnostics Inc (LUCD) basic EPS for Dec 31, 2025 was -$0.69.
What period does the latest LUCD earnings print cover?
The latest cached Lucid Diagnostics Inc (LUCD) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did LUCD revenue change from the prior cached period?
Cached Lucid Diagnostics Inc (LUCD) revenue was up 8.3% from $4.3M (Dec 31, 2024) to $4.7M (Dec 31, 2025). Statements: https://lician.com/financials/lucd
Not investment advice.